Based on the OXFYY stock forecast from 0 analysts, the average analyst target price for OXFYY is not available over the next 12 months. OXFYY’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of OXFYY is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, OXFYY’s stock price was USD 7.71. OXFYY’s stock price has changed by +0.00% over the past week, +0.00% over the past month and 0% over the last year.
No recent analyst target price found for OXFYY
No recent average analyst rating found for OXFYY
Company Overview OXFYY
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom. Read Less
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, ...Read More
Frequently Asked Questions About OXFYY (OXFYY) Stock
Stock Target Advisor's fundamental analysis for OXFYY's stock is Bearish.
Unfortunately we do not have enough data on OXFYY's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on OXFYY's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on OXFYY's stock to indicate if its overvalued.
The last closing price of OXFYY's stock was USD 7.71.
The most recent market capitalization for OXFYY is USD 1.84B.
Unfortunately we do not have enough analyst data on OXFYY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains OXFYY's stock.
As per our most recent records OXFYY has 1,281 Employees.
OXFYY's registered address is Gosling Building, Oxford, United Kingdom, OX4 4DQ.
You can get more information about it from OXFYY's website at https://nanoporetech.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About OXFYY (OXFYY) Stock
Stock Target Advisor's fundamental analysis for OXFYY's stock is Bearish.
Unfortunately we do not have enough data on OXFYY's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on OXFYY's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on OXFYY's stock to indicate if its overvalued.
The last closing price of OXFYY's stock was USD 7.71.
The most recent market capitalization for OXFYY is USD 1.84B.
Unfortunately we do not have enough analyst data on OXFYY's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains OXFYY's stock.
As per our most recent records OXFYY has 1,281 Employees.
OXFYY's registered address is Gosling Building, Oxford, United Kingdom, OX4 4DQ.
You can get more information about it from OXFYY's website at https://nanoporetech.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for OXFYY !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
